GRP and glioblastoma: Because receptors for BN/GRP are present on a high percentage of human glioblastoma cell lines, it is likely that further studies with AN-215 followed by therapeutic trials could result in the development of a new therapeutic approach for the management of patients suffering from advanced glioblastomas.